Five tobacco companies are suing the federal government over graphic cigarette warning labels that are scheduled to be on all packages by the fall of 2012. The manufacturers claim the labels violate First Amendment protections for commercial speech.
New cigarette labels required by the U.S. Food and Drug Administration that will carry graphic images of the consequences of smoking should have the desired effect of reducing demand, a new study suggests.
A Food and Drug Administration panel said Friday it needs more information about the marketing of the smokeless tobacco product called snus, before it can make recommendations about new dissolvable tobacco products.
The Food and Drug Administration is considering banning menthol cigarettes following a recent report, from its Tobacco Products Scientific Advisory Committee, that the cigarettes are extremely popular among African Americans, the poor and young.
A monthly injection to treat opioid dependence, approved in October 2010 by the U.S. Food and Drug Administration (FDA), has gotten off to a slow start but is proving useful in helping certain patients, say doctors familiar with the drug, extended-release naltrexone (Vivitrol).
The U.S. Food and Drug Administration’s Center for Tobacco Products has announced it will review research on the impact of the use of menthol in cigarettes on the public health. The independent review will evaluate the impact of the cigarettes overall, as well as on children, African Americans, Hispanics, and other racial/ethnic minorities.
A group of U.S. senators is asking the Food and Drug Administration’s Center for Tobacco Products to regulate a new form of dissolvable tobacco products that they say poses health risks, especially for children.
The Food and Drug Administration (FDA) said on Thursday that the smoking-cessation drug Chantix (vareniclene) may be associated with a small, increased risk of certain heart problems in patients with heart disease.